Obesity and Fat Metabolism Clinical trials involving 300 obese patients demonstrated tripled Body-weight change compared to placebo over 12 weeks
C., Wunschmann, J., Lendzian, K
This novel medication, developed by Eli Lilly, has shown promising results in clinical trials, offering significant benefits for people living with obesity and prediabetes
Most patients tolerate both medications well after the first few months
The GLP-1 stack amplifies results, but AOD-9604 is effective on its own, especially when combined with a caloric deficit and Zone 2 cardio
If you're getting these questions from patients and don't have a reliable pharmacy relationship yet, or you're not fully happy with the one you have, let's talk